Regeneron Pharmaceuticals (REGN) Gross Profit (2009 - 2026)
Regeneron Pharmaceuticals (REGN) reported Gross Profit of $3.71 billion for Q2 2026, up 18.1% from $3.15 billion a year earlier and up 26.5% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Gross Profit (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Regeneron Pharmaceuticals' Gross Profit came in at $13.18 billion, up 8.4% year-over-year; for FY2025, it came in at $12.24 billion, up 0.1% from FY2024.
- Gross Profit has increased for three consecutive years, with a five-year compound annual growth rate of 10.7% (FY2020 to FY2025).
- By year, Gross Profit came in at $12.23 billion in FY2024 (+8.2%), $11.3 billion in FY2023 (+6.5%), $10.61 billion in FY2022 (-22.2%) and $13.63 billion in FY2021 (+84.8%).
- The Q2 2026 figure ranks as the highest quarterly Gross Profit since Q4 2021.
- Year over year, Gross Profit has now increased in each of the last five quarters, with growth averaging 6.6% over the last eight quarters.
- The high point for year-over-year Gross Profit in five years was Q4 2021 (growth of 91.8%); the low point was Q2 2022 (a decline of 42.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.94 billion (Q1 2026), $3.3 billion (Q4 2025) and $3.23 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.71 Bn |
| Mar 31, 2026 | 2.94 Bn |
| Dec 31, 2025 | 3.30 Bn |
| Sep 30, 2025 | 3.23 Bn |
| Jun 30, 2025 | 3.15 Bn |
| Mar 31, 2025 | 2.56 Bn |
| Dec 31, 2024 | 3.22 Bn |
| Sep 30, 2024 | 3.23 Bn |
| Jun 30, 2024 | 3.07 Bn |
| Mar 31, 2024 | 2.71 Bn |
| Dec 31, 2023 | 2.92 Bn |
| Sep 30, 2023 | 2.93 Bn |
| Jun 30, 2023 | 2.75 Bn |
| Mar 31, 2023 | 2.70 Bn |
| Dec 31, 2022 | 2.87 Bn |
| Sep 30, 2022 | 2.62 Bn |
| Jun 30, 2022 | 2.56 Bn |
| Mar 31, 2022 | 2.56 Bn |
| Dec 31, 2021 | 3.97 Bn |
| Sep 30, 2021 | 3.00 Bn |
API Access
Regeneron Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();